Primary aldosteronism
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who visited the Nihon University Itabashi Hospital between January 2006 and March 2026, and who were diagnosed with primary aldosteronism or suspected of having it, and consented to participate in the study.
Exclusion criteria
Exclusion criteria: Patients who refused to participate in this study and the investigator determined to be unsuitable for study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the effectiveness (cure rate) of surgical treatment for primary aldosteronism expected by patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| factors considered by patients that influence the decision to undergo surgery, age, gender, blood pressure, BMI, blood tests (serum biochemistry test, daily fluctuation of hormones, etc.), urinalysis, confirmatory tests(captopril challenge test, furosemide and upright posture test, saline infusion test), CT scans, adrenal vein sampling, portable polysomnography, ankle brachial pressure index, cardiac ultrasound, abdominal ultrasound, carotid ultrasound, data related to treatment (antihypertensive drugs, diabetes treatment drugs, including lipid disorder treatment medications), data on lifestyle habits (smoking status, drinking status), and prognostic data (cardiovascular events, date of last follow-up) | — |
Countries
Japan
Contacts
Nihon University School of Medicine Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine